BI 831266
Modify Date: 2025-09-17 21:02:29
BI 831266 structure
|
Common Name | BI 831266 | ||
|---|---|---|---|---|
| CAS Number | 958227-46-8 | Molecular Weight | 528.098 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C27H38ClN7O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of BI 831266BI 831266 is a potent, selective inhibitor of Aurora kinase B (AURKB) with IC50 of binding IC50 of 42 nM; inhibits the proliferation of human non-small cell lung cancer (NSCLC), pancreatic cancer, and prostate cancer cell lines (H460 tumor cell proliferation inhibition IC50=11 nM); causes tumor regression and growth inhibition in in murine xenograft tumor models (HCT 116 colon carcinoma, BxPC3 pancreatic adenocarcinoma, and NCI-H460 NSCLC). Solid Tumors Phase 1 Clinical |
| Name | BI 831266 |
|---|
| Description | BI 831266 is a potent, selective inhibitor of Aurora kinase B (AURKB) with IC50 of binding IC50 of 42 nM; inhibits the proliferation of human non-small cell lung cancer (NSCLC), pancreatic cancer, and prostate cancer cell lines (H460 tumor cell proliferation inhibition IC50=11 nM); causes tumor regression and growth inhibition in in murine xenograft tumor models (HCT 116 colon carcinoma, BxPC3 pancreatic adenocarcinoma, and NCI-H460 NSCLC). Solid Tumors Phase 1 Clinical |
|---|---|
| References | References 1. Dittrich C, et al. Invest New Drugs. 2015 Apr;33(2):409-22. View Related Products by Target Aurora Kinase Solid Tumors |
| Molecular Formula | C27H38ClN7O2 |
|---|---|
| Molecular Weight | 528.098 |